Johns Hopkins receives $2.5 million NIH grant to study TLR4's role in necrotizing enterocolitis. Discover breakthrough ...
FDA pushes zanzalintinib decision to March 2027. Exelixis' colorectal cancer drug review extended by 3 months. Latest updates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results